Total Funding
2
71
Total FundingVenture - Series Unknown raised
Growth Score
-31 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
61615
Bioscience Pharma Partners provides treatment for chronic neuroinflammation in CNS disorders.
Paul B. Dumond: Chief Executive Officer- Kim A Heidenreich: Co-founder, Co-CEO, and CSO
About the Company
Bioscience Pharma Partners engages in research and development of drugs for patients. They identify and use patents for conducting Phase III human clinical trials and licensing repurposed compounds. They involve a repurposed compound as an anti-neuroinflammatory to treat numerous indications of the central nervous system, including traumatic brain
injury.
Women Founded
Women Led
